Drugs / aspargase
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05775705 | Aug 2023 → Jul 2026 | Epstein-Barr virus infection, acquired hemophagocytic lymphohistiocytosis associated with malignant disease, lymphoma | Beijing Friendship Hospital | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | aspargase | “aspargase 6000iu/m2 day2, day4;” NCT05775705 ↗ |